Joint Pain Relief
Natural health product licensed in Canada
- Licence holder
- New Roots Herbal Inc.
- NPN or DIN-HM
- 80038376
- Status
- Active licence
- Licence date
- 19 December 2012
- Revision date
- 3 June 2026
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| (1E,6E)-1,7-Bis(4-hydroxy-3-méthoxyphényl)-1,6-heptadiène-3,5-dione Source : Curcuma longa - rhizome | 100 mg | Not calculated |
| Harpagophytum procumbens Source : Racine(s) secondaire(s) tubérisée(s) Extraction ratio : 10:1 Dry plant equivalent : 1,500 mg Potency : 5 % Harpagosides | 150 mg | Not calculated |
Non-medicinal ingredients
Eau purifiée, Hypromellose, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to relieve joint pain associated with osteoarthritis. Provides antioxidants for the maintenance of good health.
NEM¿ Helps provide relief from joint pain due to moderate intensity aerobic exercise (as quickly as 1 day). NEM¿ is Clinically proven to provide relief from joint stiffness due to moderate intensity aerobic exercise (in as little as 5 days). NEM® increases joint flexibility. NEM® helps reduce joint pain and stiffness. NEM® helps to relieve joint pain and stiffness associated with osteoarthritis (of the knee). NEM® helps to improve recovery from joint pain and stiffness due to moderate intensity aerobic exercise in post-menopausal women NEM® helps to minimize discomfort due to moderate intensity aerobic exercise in post-menopausal women. NEM® helps reduce levels of CTX-II, a biomarker/marker of cartilage degradation due to moderate intensity aerobic exercise in post-menopausal women. NEM® helps reduce levels of CTX-II, a biomarker/marker of joint degradation due to moderate intensity aerobic exercise in post-menopausal women.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80038376
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.